The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.95
Bid: 1.90
Ask: 2.00
Change: -0.05 (-2.50%)
Spread: 0.10 (5.263%)
Open: 1.95
High: 2.00
Low: 1.95
Prev. Close: 2.00
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Genedrive test to go through new, faster NICE process

Mon, 26th Sep 2022 14:10

(Sharecast News) - Molecular diagnostics technology company Genedrive announced on Monday that the UK's National Institute for Health and Clinical Excellence (NICE) has transferred the evaluation of its 'MT-RNR1' test to a new 'early value assessment programme'.

The AIM-traded firm said the programme is a new review process, created to drive innovation into the hands of healthcare professionals by actively drawing in digital products, medical devices and diagnostics that address national unmet needs.

It said the programme would allow the NICE diagnostics advisory committee to consider the technology "much faster", resulting in a published report in a six month timeframe instead of the initial 63 weeks - approximately 14 months - via the diagnostics assessment programme.

A provisional schedule was published by NICE, indicating the consultation process would occur in February.

Genedrive described the MT-RNR1 assay as "the world's first" rapid point-of-care test to screen infants in an urgent care setting for a genetic variant that would cause life-long hearing loss when carriers of the variant were given certain antibiotics.

Those that carry the variant could then be given alternative treatments following detection of the variant by the Genedrive test.

"We are grateful to NICE for their engagement and interest in our innovative technology and pleased that the Genedrive MT-RNR1 test has been fast tracked via their new EVA programme, which may allow clinicians and patients to benefit from the test sooner," said chief executive officer David Budd.

"This is a testament to our technology and our ability to address this unmet need."

At 1309 BST, shares in Genedrive were up 2.13% at 12p.

Reporting by Josh White at Sharecast.com.

More News
18 Mar 2021 16:06

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Mar 2021 14:34

IN BRIEF: Genedrive to distribute pathogen detection assays in US

IN BRIEF: Genedrive to distribute pathogen detection assays in US

Read more
3 Mar 2021 21:53

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

TRADING UPDATES: Team PLC prices IPO; Nostra's Cypress doubles

Read more
17 Feb 2021 11:27

AIM WINNERS & LOSERS: Blockchain Stocks Rise As Bitcoin Hits New High

AIM WINNERS & LOSERS: Blockchain Stocks Rise As Bitcoin Hits New High

Read more
17 Feb 2021 09:32

Genedrive Makes First Shipments Of SARS-CoV-2 Test Kits To US

Genedrive Makes First Shipments Of SARS-CoV-2 Test Kits To US

Read more
28 Jan 2021 14:26

IN BRIEF: Genedrive Soars After Sealing PCR Test Distribution Deal

IN BRIEF: Genedrive Soars After Sealing PCR Test Distribution Deal

Read more
28 Jan 2021 10:22

AIM WINNERS & LOSERS: Eurasia Rallies As It Explains Churakov Sale

AIM WINNERS & LOSERS: Eurasia Rallies As It Explains Churakov Sale

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
16 Dec 2020 12:16

Genedrive notifies FDA of intent to distribute Covid test

(Sharecast News) - Molecular diagnostics company Genedrive has notified the United States Food and Drug Association (FDA) of its intention to import and distribute its 'Genedrive 96 SARS-CoV-2 Kit' prior to an emergency use authorisation (EUA) determination, it announced on Wednesday.

Read more
16 Dec 2020 11:04

IN BRIEF: Genedrive To Commence Covid Testing Kit Distribution In US

IN BRIEF: Genedrive To Commence Covid Testing Kit Distribution In US

Read more
11 Dec 2020 19:34

IN BRIEF: Genedrive To Issue Shares To BGF After Loan Note Conversion

IN BRIEF: Genedrive To Issue Shares To BGF After Loan Note Conversion

Read more
3 Dec 2020 19:58

UK TRADING UPDATE SUMMARY: BMO Commercial Free From Arcadia, Debenhams

UK TRADING UPDATE SUMMARY: BMO Commercial Free From Arcadia, Debenhams

Read more
20 Nov 2020 19:26

IN BRIEF: Genedrive's HCV ID Kit Deemed Suitable For Use In India

IN BRIEF: Genedrive's HCV ID Kit Deemed Suitable For Use In India

Read more
17 Nov 2020 14:49

UK EARNINGS SUMMARY: Focusrite Revenue Up Over 50% On Acquisitions

UK EARNINGS SUMMARY: Focusrite Revenue Up Over 50% On Acquisitions

Read more
22 Oct 2020 17:42

IN BRIEF: Genedrive Completes Assay Design For Covid Testing Solution

IN BRIEF: Genedrive Completes Assay Design For Covid Testing Solution

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.